Protas’ Post

Celebrate #ClinicalTrialsDay today by checking out the newly released Toward a National Action Plan for Achieving Diversity in Clinical Trial, which includes eight domains and action steps intended to drive system-wide collective action. The need to improve diversity in clinical trials has been evident for many years, but a multi-sector action plan for system-wide, sustainable change was lacking. This foundational document is a call to collective action that has been (and continues to be) informed by the shared wisdom of hundreds of leaders in health equity and representation involved in a series of convenings over the last year. These include meetings held by the Clinical Trials Transformation Initiative (CTTI) in June 2023, the Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) in September 2023, Milken Institute’s FasterCures in November 2023, and the meeting today May 20, 2024, hosted by the National Academies Forum on Drug Discovery, Development, and Translation. We call on each of us from across the clinical research enterprise to step forward and commit to working together to implement this National Action Plan and achieve representative clinical trials. https://lnkd.in/eYa3nNYW

📢 In Clinical Research News’s latest story, our Founder and President Gen Li, PhD, MBA discusses the over-collection of data in clinical trials. Gen delves into the findings from #Phesi's recent Trial Complexity study, explaining why investigators must be precise with outcome measures to enable easier trial site selection, recruit more patients in a shorter period of time, and collect better quality data. 🔬 📰 Read more here: https://lnkd.in/e_fPejuM #ClinicalTrials #ClinicalDevelopment

Ensuring Access Beyond Trials: A Framework for Continued Care    Post-trial responsibilities are a critical aspect of ethical clinical research, particularly when it comes to continued access to investigational medicines. The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Center is proud to provide a Framework for Post-Trial Continued Access to Investigational Medicines to guide sponsors, researchers, and stakeholders in navigating these complex responsibilities.    This comprehensive resource complements our foundational Principles on Post-Trial Responsibilities by offering actionable guidance on:    ✅ Identifying and addressing potential barriers to continued access.  ✅ Clarifying roles and responsibilities for stakeholders.  ✅ Developing equitable and sustainable approaches to ensure participant care.    Together, these tools aim to foster trust, transparency, and ethical stewardship in clinical trials, ensuring participants are supported beyond the study’s conclusion.    Explore the framework and join us in advancing participant-centered research: Framework for Post-Trial Continued Access to Investigational Medicines: https://lnkd.in/eCAE6GMz    #ClinicalResearch #EthicalResearch #ParticipantAdvocacy #PostTrialAccess #MRCTCenter   

Today is International Clinical Trials Day. It’s an important day to recognise and reflect on all that has been accomplished thanks to clinical trials and the people behind them. Gilead ANZ plays an important role supporting clinical trials, engaging with some of the world’s best researchers working across a strong local clinical trial ecosystem. Today we also acknowledge and thank the patients, as without them clinical trials would not be possible. Your efforts drive progress and hope for a healthier future. #ClinicalTrialsDay #InternationalClinicalTrialsDay

Celebrating Innovation and Dedication on Clinical Trials Day 2024 🎉 Today, we honour the incredible contributions of clinical researchers and participants around the world on Clinical Trials Day. Their unwavering commitment to advancing medicine has played a pivotal role in enhancing healthcare for us all ❗ Clinical trials are the backbone of medical progress, providing us with valuable insights and leading to breakthroughs that save lives. The journey from the laboratory 🔬 to the patient’s bedside 🛏 is long and complex, but it’s through the dedication of countless individuals that we can turn possibilities into realities. Here are some impactful statistics that highlight the significance of clinical trials: ✔ The Association of Clinical Research Professionals (ACRP) has more than 16,500 members globally, representing a diverse and dedicated workforce. ✔ Clinical Trials Day is a tradition since 2014, celebrating the achievements and progress made through clinical research. ✔ The 2024 theme, “Trailblazers Among Us,” emphasizes the relentless pursuit of knowledge and the exacting application of best practices by clinical research professionals. Let’s take a moment to appreciate the hard work, innovation, and collaboration that go into every study. It’s through these efforts that we can look forward to a healthier future for everyone. 🙏 Thank you to all the researchers, healthcare professionals, and trial participants who make this possible. Your work does not go unnoticed, and the impact of your contributions will be felt for generations to come. #WeAreIQVIA #ClinicalTrialsDay #cFSPCares #SMSupports #HealthcareHeroes If you'd like to explore more about clinical trial conducted at IQVIA click on the link!

Excited to join this webinar! Research professionals interested, this is a free webinar including topics of: " Strategies for developing an effective, integrative diversity action plan, Insights from leaders across regulatory, industry and academic fields and Techniques for managing data variability to support inclusive clinical trials "

Great comprehensive overview: Strategic Emergence of Site Networks in Clinical Research from Applied Clinical Trials. Integrated site networks are emerging rapidly in the clinical research industry. https://lnkd.in/gk_Tmb-4 #sitenetwork #clinicalresearch #clinicaltrials

The FDA and The National Institutes of Health introduce a draft glossary for consistent clinical and #RWE research terminology and seek public feedback on the terms suggested. Read at The Evidence Base® #rwd #realworldevidence #realworlddata

📆 Today is International Clinical Trials Day! Clinical trials are used to assess the safety, efficacy, and use of treatment in humans so that a new medicine can be put on the market. One important aspect when initiating a clinical trial is making sure that the sample group is representative of the patient population. Recruiting patients from a variety of backgrounds allows us to refine the results in terms of treatment efficacy and safety according to the patient profile. At Servier, the clinical trials are managed by expert teams in 15 clinical development centers 🔬 divided into 3 hubs in the North and South America, Europe, and Asia-Pacific. According to Marta Garcia, Chief Patient Officer R&D at Servier, 🗣 “Our global geographic footprint, local teams’ high degree of expertise, and our new hybridized trial models are what put us in a position to improve our clinical developments every day – improvements not only in the diversity of the patients in our trials, but also in our understanding of local characteristics. It likewise allows us to forge stronger ties with the health care professionals and investigator centers involved.” Read more about Servier’s clinical trials 🗣 https://swll.to/dYA5g #CTD2024 #InternationalClinicalTrialsDay #ClinicalTrials #MovedByYou

Discover strategies to boost enrollment at clinical research sites in our latest blog. Get actionable tips to address common challenges and ensure successful clinical trials. » https://bit.ly/3ZMrle2 #clinicalresearch #nonenrollingsites #researchsites